The Global Cord Blood and Tissue Banking Services Market is composed of revenue produced by companies that are engaged with the collection, processing, storage, and release of umbilical cord blood and tissue products. The global cord blood industry came into existence in the early 1990’s with the formation of a handful of cord blood banks within the United States. Shortly thereafter, these companies began being established in other regions as well. [Read more…]
LifeCell International, India’s Largest Cord Blood Bank
LifeCell is India’s largest cord blood bank, offering stem cell banking services and diagnostic testing. Established in 2004, its BabyCord program is one of the largest cord blood banking programs in the region, with 50,000+ parents preserving newborn stem cells each year and 375,000 units cryopreserved.
I had the privilege of interviewing Mr. Mayur Abhaya Srisrimal, Chief Executive Officer and Managing Director of LifeCell. Mr. Abhaya has led LifeCell since 2008 and been instrumental in expanding its stem cell storage services across India with its BabyCord program. Under his leadership, LifeCell also raised growth capital from Helion Ventures and extended its preventive diagnostic services by launching BabyShield, a program targeted at reducing the infant mortality ratio. [Read more…]
The Emerging Role of Exosome Therapeutics in 2024
Exosomes are extracellular vesicles (EVs) of endosomal origin that range in size between 30 and 150 nanometers. Exosomes are secreted by a wide range of cells, since virtually all living cells utilize exosome-mediated communication. Exosomes carry cell-specific cargos of proteins, lipids, and nucleic acids that are selectively taken up by recipient cells. [Read more…]
History of Cord Blood and Tissue Banking: Landmark Events and Pivotal Trends
The global cord blood industry came into existence in the early 1990’s with the formation of several leading cord blood banks in the USA, followed by the establishment of cord blood banks across the globe. However, the history of cord blood stem cell transplantation begins much earlier than that. [Read more…]
Cell Therapy CDMOs – Role Of Contract Manufacturing For Cell Therapies
Among cell therapy companies, the pressure to manufacture innovation and optimization can incentivize them to seek third-party partners who possess technical, manufacturing, and regulatory expertise, such as cell therapy contract and development manufacturing organizations (CDMOs). Currently, there are an incredible 135 different CDMOs specializing in manufacturing and clinical trial support for cell and gene therapy developers.
Benefits of partnering with a cell therapy CDMO include scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies. [Read more…]
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 314
- Next Page »